ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Camzyos 5 mg, Hartkapseln - 28
68477003 Bristol-Myers Squibb SA
Camzyos 5 mg, Hartkapseln25.04.2023
  25.04.2023
Mavacamten (C01EB24) 
WHO-DDD24.04.2028
02.99.28
02.99. 
B  
Yes 
IP 
1403.91Yes
    
10 %1602.80
  
7680684770036Synthetika
  
Composition
mavacamtenum 5 mg, silica colloidalis hydrica, mannitolum, hypromellosum, carmellosum natricum conexum, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (flavum), Drucktinte: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), ammoniae solutio concentrata, pro capsula corresp. natrium 1.05 mg.
Packungsbestandteile
Capsules 
  
 
Active AgentDose
Mavacamtenum5 mg
BAG: Active AgentDose
Mavacamtenum5 mg
 
Inactive agents additional_information
(Flavum)  
(Nigrum)  
Ammoniae Solutio Concentrata  
Carmellosum Natricum Conexum  
E 171 color.
E 172 color.
Gelatina Kapselhülle
Hypromellosum  
Kalii Hydroxidum  
Lacca Drucktinte
Magnesii Stearas  
Mannitol  
Propylenglycol  
Silica Colloidalis Hydrica  
 
Source
Data was imported : 04.05.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home